Echocardiographic Examination of Women Previously Treated With Fenfluramine | Zendy

Ravin Davidoff | Zendy; Anne McTiernan | Zendy; Ginger D. Constantine | Zendy; Kelly Davis | Zendy; Gary Balady | Zendy; Lisa A. Mendes | Zendy; Rebecca E. Rudolph | Zendy; Deborah J. Bowen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Echocardiographic Examination of Women Previously Treated With Fenfluramine

Author(s) -

Ravin Davidoff,

Anne McTiernan,

Ginger D. Constantine,

Kelly Davis,

Gary Balady,

Lisa A. Mendes,

Rebecca E. Rudolph,

Deborah J. Bowen

Publication year - 2001

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.161.11.1429

Subject(s) - fenfluramine , medicine , ejection fraction , placebo , cardiology , mitral regurgitation , regurgitation (circulation) , blood pressure , surgery , heart failure , receptor , alternative medicine , pathology , serotonin

Fenfluramine hydrochloride was withdrawn from the market in September 1997 after reports of heart valve abnormalities in patients who used it. The prevalence of echocardiographic abnormalities and the clinical cardiovascular status of patients who received fenfluramine monotherapy remains uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research